REFERENCES
P. T. Reeves, R. F. Minchin, and K. F. Ilett. In-vivo mechanisms for the enhanced acetylation of sulfamethazine in the rabbit after hydrocortisone treatment. J. Pharmacol. Exp. Ther. 248:348–352 (1989).
P. du Souich, D. Lalka, R. Slaughter, A. T. Elvin, and A. J. McLean. Mechanisms of nonlinear disposition of sulfamethazine. Clin. Pharmacol. Ther. 25:172–183 (1979).
W. W. Weber and D. W. Hein. N-Acetylation pharmacogenetics. Pharmacol. Rev. 37:25–79 (1985).
P. T. Reeves, R. F. Minchin, and K. F. Ilett. Induction of sulfamethazine by hydrocortisone in the rabbit. Drug Metab. Dispos. 16:110–115 (1988).
M. Gibaldi and D. Perrier. Pharmacokinetics, 2nd ed., Marcell Dekker, New York, 1982.
R. M. Lindsay and J. D. Baty. The effect of streptozotocin-induced diabetes on the in vivo acetylation capacity and the in-vitro blood N-acetyltransferase activity of the adult male Sprague-Dawley rat. Biochem. Pharmacol. 39:1193–1197 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Svensson, C.K., Zaher, H. & Tomilo, M. Disposition of Sulfamethazine and N-Acetylsulfamethazine in the Rat. Pharm Res 8, 1069–1070 (1991). https://doi.org/10.1023/A:1015877612600
Issue Date:
DOI: https://doi.org/10.1023/A:1015877612600